Cigna CorpEvernorth launches $100M AI program to accelerate prescription processing and improve adherence, expected to generate $0.4B value by 2028.

Evernorth, The Cigna Group's health services division, launched Pharmacy Forward, a US$100 million AI-powered program through its Accredo specialty pharmacy, aiming to accelerate prescription processing, improve adherence, and cut clinician documentation time. The program is expected to generate about US$0.40 billion in value by 2028, halve time-to-medication, and place 90% of patients within a one-day or same-day shipping radius. Evernorth now generates roughly four-fifths of Cigna's revenue and delivered US$7.221 billion of pre-tax adjusted income in 2025, making this investment central to the group's specialty pharmacy growth narrative. Cigna's projections target US$315.1 billion in revenue and US$7.8 billion in earnings by 2029, requiring 4.3% annual revenue growth and a US$1.5 billion earnings increase from the current US$6.3 billion. The launch reinforces near-term growth but does not alter key risks from potential regulatory or pricing pressures on the PBM and specialty pharmacy model.
Cigna CorpEvernorth launches $100M AI program to accelerate prescription processing and improve adherence, expected to generate $0.4B value by 2028.